Search for Clinical Trial Results
Becker Muscular Dystrophy - 196 Studies Found
Status | Study |
Completed |
Study Name: CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers Condition:
|
Active, not recruiting |
Study Name: Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis Condition:
Date: 2012-01-23 Interventions: Biological: rAAV1.CMV.huFollistatin344 |
Completed |
Study Name: Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I Condition:
|
Completed |
Study Name: Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy Condition: Becker Muscular Dystrophy Date: 2014-03-25 Interventions:
|
Completed |
Study Name: Functional Muscle Ischemia With Tadalafil Treatment in Becker Muscular Dystrophy Condition: Becker Muscular Dystrophy Date: 2014-09-23 Interventions:
|
Completed |
Study Name: High-dose Prednisone in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2005-05-12 Interventions: Drug: Prednisone Prednisone and dummy preparations for this study will be obtained from Frank's Pharmacy |
Completed |
Study Name: Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients Condition: Becker Muscular Dystrophy Date: 2011-05-04 Interventions:
|
Recruiting |
Study Name: An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2016-09-14 Interventions: Biological: PF-06252616 Either 5mg/kg, 20mg/kg or 40mg/kg will be assigned to a subject based on their m |
Recruiting |
Study Name: A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2014-11-04 Interventions:
|
Withdrawn |
Study Name: Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2 Condition: Duchenne Muscular Dystrophy Date: 2015-12-23 Interventions:
|